BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24552991)

  • 1. Depression and antidepressants: molecular and cellular aspects.
    Lanni C; Govoni S; Lucchelli A; Boselli C
    Cell Mol Life Sci; 2009 Sep; 66(18):2985-3008. PubMed ID: 19521663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders.
    Sanacora G; Banasr M
    Biol Psychiatry; 2013 Jun; 73(12):1172-9. PubMed ID: 23726152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlocking Therapeutic Synergy: Tailoring Drugs for Comorbidities such as Depression and Diabetes through Identical Molecular Targets in Different Cell Types.
    Coppola T; Daziano G; Legroux I; Béraud-Dufour S; Blondeau N; Lebrun P
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neurocognitive model for understanding treatment action in depression.
    Warren MB; Pringle A; Harmer CJ
    Philos Trans R Soc Lond B Biol Sci; 2015 Sep; 370(1677):20140213. PubMed ID: 26240428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinase-mediated signaling cascades in mood disorders and antidepressant treatment.
    Yuan LL; Wauson E; Duric V
    J Neurogenet; 2016; 30(3-4):178-184. PubMed ID: 27785950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurosteroid influence on affective tone.
    Walton NL; Antonoudiou P; Maguire JL
    Neurosci Biobehav Rev; 2023 Sep; 152():105327. PubMed ID: 37499891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological Effects of Antidepressants: Translational Studies.
    Kamenish K; Robinson ESJ
    Curr Top Behav Neurosci; 2023 Nov; ():. PubMed ID: 37955824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: The pharmacotherapy of depression-searching for new mechanisms and drug interactions. Basic and clinical research, volume II.
    Stachowicz K; Sowa-Kućma M; Tabecka-Łonczyńska A
    Front Pharmacol; 2024; 15():1402761. PubMed ID: 38595922
    [No Abstract]   [Full Text] [Related]  

  • 9. From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment.
    Fabbri C; Porcelli S; Serretti A
    Can J Psychiatry; 2014 Feb; 59(2):62-75. PubMed ID: 24881125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections.
    Duman RS
    Depress Anxiety; 2014 Apr; 31(4):291-6. PubMed ID: 24616149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant-like effects of Gan-Mai-Dazao-Tang via monoamine regulatory pathways on forced swimming test in rats.
    Huang HL; Lim SL; Lu KH; Sheen LY
    J Tradit Complement Med; 2018 Jan; 8(1):53-59. PubMed ID: 29321989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome.
    Roomruangwong C; Kanchanatawan B; Sirivichayakul S; Anderson G; Carvalho AF; Duleu S; Geffard M; Maes M
    Mol Neurobiol; 2017 May; 54(4):3038-3049. PubMed ID: 27037573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New trends in the neurobiology and pharmacology of affective disorders.
    Lasoń W; Budziszewska B; Basta-Kaim A; Kubera M; Maes M
    Pharmacol Rep; 2013; 65(6):1441-50. PubMed ID: 24552991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of antidepressants: clinical pharmacology and therapy.
    Baldessarini RJ
    J Clin Psychiatry; 1989 Apr; 50(4):117-26. PubMed ID: 2647712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence.
    Ferrari F; Villa RF
    Mol Neurobiol; 2017 Sep; 54(7):4847-4865. PubMed ID: 27510505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action.
    Sanacora G; Saricicek A
    CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):127-40. PubMed ID: 17430150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurobiology of depression and antidepressant action.
    Willner P; Scheel-Krüger J; Belzung C
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 1):2331-71. PubMed ID: 23261405
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.